Nina Bake is CEO of Episurf Medical. The company has developed an implant, a few millimeters wide, which among other things is supposed to repair a cartilage injury in the knee joint.
This method means that the implant will replace what is damaged – not the whole trail. Now, the company implements a controlled product launch of orthopedic surgeons and clinics in Europe. A full-scale launch is expected later this year.
In 2010 the company took the step into AktieTorget and two years later, stepping on to First North. Now looms the Stockholm Stock Exchange. The plan is a listing of the shares in the second quarter.